Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | -23.58% | -32.33% | -8.74% | -19.58% | -13.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -23.58% | -32.33% | -8.74% | -19.58% | -13.77% |
| Cost of Revenue | -30.15% | -32.56% | -15.67% | -19.29% | -9.80% |
| Gross Profit | -14.06% | -32.07% | 11.09% | -20.11% | -18.95% |
| SG&A Expenses | -32.77% | -23.22% | -22.85% | 10.24% | 13.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.10% | -28.38% | -16.86% | -7.24% | -0.26% |
| Operating Income | 74.22% | -120.43% | 53.24% | -178.36% | -1,745.63% |
| Income Before Tax | 42.18% | -174.64% | 33.52% | -104.78% | -307.96% |
| Income Tax Expenses | -- | -- | -- | -- | -100.00% |
| Earnings from Continuing Operations | 42.18% | -174.64% | 33.50% | -100.11% | -265.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.18% | -174.64% | 33.50% | -100.11% | -265.63% |
| EBIT | 74.22% | -120.43% | 53.24% | -178.36% | -1,745.63% |
| EBITDA | 94.32% | -74.09% | 62.99% | -374.61% | -340.58% |
| EPS Basic | 42.31% | -174.19% | 33.76% | -100.00% | -264.00% |
| Normalized Basic EPS | 42.11% | -178.95% | 34.90% | -104.11% | -307.14% |
| EPS Diluted | 47.50% | -222.58% | 15.61% | -100.00% | -300.00% |
| Normalized Diluted EPS | 42.11% | -178.95% | 34.90% | -104.11% | -307.14% |
| Average Basic Shares Outstanding | 0.10% | 0.13% | 0.14% | 0.13% | 0.13% |
| Average Diluted Shares Outstanding | 0.10% | 0.13% | 0.14% | 0.13% | 0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
